The role of HPV DNA testing in the follow-up period after treatment for CIN: A systematic review of the literature

Cancer Treatment Reviews

Volumn 30, Issue 2, 2004, Pages 205-211

  Paraskevaidis, Evangelos ^a   Arbyn, Marc ^b   Sotiriadis, Alexandros ^a   Diakomanolis, Emmanuel ^c   Martin Hirsch, Pierre ^d   Koliopoulos, George ^a   Makrydimas, George ^a   Tofoski, Jovan ^e   Roukos, Dimitrios H ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c UNIVERSITY OF ATHENS   (Greece)

^d Preston Hospital   (United Kingdom)

^e University Hospital of Skopje   (Macedonia)

Author keywords

CIN; Follow up; HPV; HPV DNA testing; LLETZ

Indexed keywords

VIRUS DNA;

CANCER RECURRENCE; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; DNA PROBE; ELECTROSURGERY; EMBASE; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MEDLINE; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; PAPILLOMA VIRUS; PREDICTION AND FORECASTING; STANDARD; UTERINE CERVIX TUMOR; VIRUS INFECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 1642617694     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2003.07.008     Document Type: Review

References (21)

1. Kitchener HC, Cruickshank ME, Farmery E. The 1993 British Society for Colposcopy and Cervical Pathology/National Coordinating Network United Kingdom Colposcopy Survey. Comparison with 1988 and the response to introduction of guidelines. Br J Obstet Gynaecol 1995;102(7):549-52.
2. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software; 2002.
3. Nuovo J, Melnikow J, Willan AR, Chan BK. Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet 2000;68:25-33.
4. Paraskevaidis E, Jandial L, Mann EM, et al. Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol. Obstet Gynecol 1991;78:80-3.
5. Chew GK, Jandial L, Paraskevaidis E, Kitchener HC. Pattern of CIN recurrence following laser ablation treatment: long-term follow-up. Int J Gynecol Cancer 1999;9:487-90.
6. Jansen FW, Trimbos JB, Hermans J, Fleuren GJ. Persistent cervical intraepithelial neoplasia after incomplete conization: predictive value of clinical and histological parameters. Gynecol Obstet Invest 1994;37:270-4.
7. Skjeldestad FE, Hagen B, Lie AK, Isaksen C. Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 1997;90:428-33.
8. Paraskevaidis E, Lolis DE, Koliopoulos G, et al. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstet Gynecol 2000;95:828-31.
9. Soutter WP, de Barros Lopes A, Fletcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-80.
10. Paraskevaidis E, Koliopoulos G, Alamanos Y, et al. Human Papillomavirus testing in the prediction of the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2001;98:833-6.
11. Elfgren K, Bistoletti P, Dillner L, et al. Conization for cervical intraepithelial neoplasia is follwed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol 1996;174:937-42.
12. Chua KL, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 1997;66:108-13.
13. Distefano AL, Picconi MA, Alonio LV, et al. Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision. Infect Dis Obstet Gynecol 1998;6:214-9.
14. Bollen LJ, Tjong-A-Hung SP, van der Velden J, et al. Prediction of recurrent and residual dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 1999;72:199-201.
15. Nagai Y, Maehama T, Asato T, Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 2000;79:294-9.
16. Kjellberg L, Wadell G, Bergaman F, et al. Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. Am J Obstet Gynecol 2000;183:1238-42.
17. Lin CT, Tseng CJ, Lai CH, et al. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 2001;184: 940-5.
18. Nobbenhuis MAE, Meijer CJLM, van der Brule AJC, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001;84:796-801.
19. Kucera E, Sliutz G, Czervenka K, et al. Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 2001;100:72-6.
20. Acladious N, Sutton CJ, Mandal D, et al. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of CIN. Int J Cancer 2002;98:435-9.
21. Jain S, Tseng CJ, Horng SG, et al. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 2001;82:177-80.